Stocks and Investing Stocks and Investing
Wed, November 16, 2016

David Risinger Downgraded (TEVA) to Hold and Decreased Target to $42 on, Nov 16th, 2016


Published on 2024-10-25 19:20:39 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Decreased Target from $63 to $42 on, Nov 16th, 2016.

David has made no other calls on TEVA in the last 4 months.



There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016
  • Sumant Kulkarni of "B of A Securities" Downgraded from Strong Buy to Hold on, Monday, November 7th, 2016
  • Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016


These are the ratings of the 3 analyists that currently disagree with David


  • Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016
  • Derek Archila of "Oppenheimer" Upgraded from Hold to Buy on, Friday, September 2nd, 2016
  • Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016

Contributing Sources